Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Hisse Senetlerindeki Sıralama #29827
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Hisse Fiyatı
$7.00
Son senkronizasyon: 2026-08-17
Piyasa Değeri
$19.47M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-35.19%
Ülke
CA
Ticaret Devonian Health Group Inc. (DVHGF)

Kategori

Devonian Health Group Inc. (DVHGF) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $7.00 - 2026-08-01

Gün sonu en düşük fiyat: $35.44 - 2022-09-01
Devonian Health Group Inc. için hisse fiyatı geçmişi: 2022 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 73.19%
2025 -46.13%
2024 -38.22%
2023 -14.47%
2022 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$735.86 6.07%
CH
$1.07K -5.58%
KR